Myeloid Therapeutics, Inc.
Industry
- Biotechnology
- Antisense, Oligonucleotides
- Gene Therapy, Cell Therapy
- Pharmaceuticals
Latest on Myeloid Therapeutics, Inc.
After the year’s slow start, venture capital fundraising by drug developers has gotten a big boost in recent months, especially in May when two companies raised more than $700m between them – $300m fo
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Innoviva Acquisition Of Entasis Leaves
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Jazz Moves Into IO With Engineered IFN⍺
Ten biopharmaceutical companies launched initial public offerings in the US during the last week of July, raising $1.2bn combined, bringing last month’s total to 18 IPOs. Added to the 62 first-time of